비혈관 스텐트 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Non-vascular Stents Market size is expected to reach USD 3.59 Billion in 2034 from USD 2.26 Billion (2025) growing at a CAGR of 5.26% during 2026-2034.

The Global Non-vascular Stents Market is experiencing stable growth driven by increasing cases of gastrointestinal, urological, and pulmonary disorders. Non-vascular stents are used to treat blockages in organs such as the esophagus, bile ducts, and ureters. Growing awareness about minimally invasive procedures and improved diagnostic techniques are contributing to higher adoption rates worldwide.

Major growth drivers include technological advancements in stent materials and designs, offering better flexibility and patient comfort. The rising geriatric population and increasing incidence of cancer-related complications are also supporting demand. Additionally, improvements in healthcare infrastructure and the availability of skilled professionals are strengthening market expansion.

Future prospects for the market remain positive, supported by continuous product innovation and research in biodegradable and drug-eluting stents. Increasing healthcare spending and broader access to advanced treatment options will further drive growth. As minimally invasive procedures become more common, non-vascular stents are expected to see steady demand in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Gastrointestinal Stents (Biliary, Duodenal, Colonic, Pancreatic)
• Esophageal Stents
• Pulmonary (Airway) Stents (Silicone Airway, Metallic Airway)
• Urological Stents
• Others

By End Use

• Hospitals
• Ambulatory Care Centers (ACS)
• Specialty Clinics

COMPANIES PROFILED

• Medtronic, BD, Boston Scientific Corporation, ELLA CS, sro, Conmed Corporation, Hobbs Medical Inc, Cook, Taewoong, Glaukos Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NON-VASCULAR STENTS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Gastrointestinal Stents (Biliary, Duodenal, Colonic, Pancreatic) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Esophageal Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Pulmonary (Airway) Stents (Silicone Airway, Metallic Airway) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Urological Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NON-VASCULAR STENTS MARKET: BY END USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Use
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Ambulatory Care Centers (ACS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NON-VASCULAR STENTS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Type
  • 6.2.2 By End Use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Type
  • 6.3.2 By End Use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Type
  • 6.4.2 By End Use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Type
  • 6.5.2 By End Use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Type
  • 6.6.2 By End Use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL NON-VASCULAR STENTS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Medtronic
  • 8.2.2 BD
  • 8.2.3 Boston Scientific Corporation
  • 8.2.4 ELLA - CS
  • 8.2.5 S.R.O
  • 8.2.6 Conmed Corporation
  • 8.2.7 Hobbs Medical Inc
  • 8.2.8 Cook
  • 8.2.9 Taewoong
  • 8.2.10 Glaukos Corporation